以外体为基础的miRNA传递:通过介质细胞干细胞改变癌症治疗
Ashok Kumar Balaraman1, M Arockia Babu2, Muhammad Afzal3
1Research and Enterprise, University of Cyberjaya, Persiaran Bestari, Cyber 11, Cyberjaya, Selangor, 63000, Malaysia.
Regenerative therapy
|March 4, 2025
概括
介酶干细胞衍生的细胞外囊泡 (MSC-EVs) 显示出针对性miRNA癌症治疗的前景. 这些纳米载体可以抑制瘤生长并增强治疗方法,但生产和稳定性的挑战仍然存在.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 纳米技术纳米技术
背景情况:
- 介质细胞干细胞衍生的细胞外囊泡 (MSC-EVs),特别是外体,被探索为纳米载体用于癌症治疗中的miRNA输送.
- 它们固有的生物相容性,低免疫性和瘤定位能力使它们适合于向药物输送.
研究的目的:
- 研究装载有治疗性miRNA的MSC-EV在癌症治疗中的潜力.
- 概述miRNA加载的机制,准效率和治疗结果.
- 讨论MSC-EV工程和临床应用策略的当前进展.
主要方法:
- 将治疗性miRNA加载到MSC-EV中,以保护它们免受降解.
- 在体外和体内实验中评估miRNA载的MSC-EV的疗效.
- 分析MSC-EV工程和临床翻译策略.
主要成果:
- 装有miRNAs的MSC-EV显示出抑制瘤生长和转移的潜力.
- 这些纳米载体可能会增强化疗和放射治疗的有效性.
- 挑战包括隔离,可扩展性,miRNA稳定性,非目标效应和免疫性.
结论:
- 装有miRNA的MSC-EV代表了精确瘤学的有前途的第二代工具.
- 需要进一步的研究来克服成功临床应用目前的局限性.
相关概念视频
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K